Literature DB >> 15672548

Changes of [3H]MK-801, [3H]muscimol and [3H]flunitrazepam binding in rat brain by the prolonged ventricular infusion of transformed ginsenosides.

Soyong Jang1, Jong Hoon Ryu, Dong-Hyun Kim, Seikwan Oh.   

Abstract

Ameliorating effects of ginseng were observed on neuronal cell death associated with ischemia or glutamate toxicity. Ginseng saponins are transformed by intestinal microflora and the transformants would be absorbed from intestine. In the present study, we have investigated the effects of transformed ginsenoside Rg3, Rh2 and compound K on the modulation of NMDA receptor and GABAA receptor binding in rat brain. The NMDA receptor binding was analyzed by quantitative autoradiography using [3H]MK-801 binding, and GABAA receptor bindings were analyzed by using [3H]muscimol and [3H]flunitrazepam binding in rat brain slices. Ginsenoside Rg3, Rh2 and compound K were infused (10 microg/10 microl/h) into rat brain lateral ventricle for 7 days, through pre-implanted cannula by osmotic minipumps (Alzet, model 2ML). The levels of [3H]MK-801 binding were highly decreased in almost all regions of frontal cortex and hippocampus by ginsenoside Rh2 and compound K. The levels of [3H]muscimol binding were elevated in part of frontal cortex and granule layer of cerebellum by the treatment of ginsenoside Rh2 and compound K. However, the [3H]flunitrazepam binding was not modulated by any tested ginsenosides. Ginsenoside Rh2 and compound K induced the downregulation of the [3H]MK-801 binding as well as upregulation of the and [3H]muscimol binding in a region-specific manner after prolonged infusion into lateral ventricle. However, ginsenoside Rg3 did not show the significant changes of ligand bindings. In addition, ginsenoside Rh2 decreased the expression of nNOS in the hippocampus although Rg3 decreased the expression in the cortex. These results suggest that biotransformed ginsenoside Rh2 and compound K could play an important role in the biological activities in the central nervous systems and neurodegenerative disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15672548     DOI: 10.1007/s11064-004-7034-2

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  43 in total

1.  Multiple channel interactions explain the protection of sympathetic neurons from apoptosis induced by nerve growth factor deprivation.

Authors:  Shuli Xia; Patricia A Lampe; Mohanish Deshmukh; Aizhen Yang; Barry S Brown; Steve M Rothman; Eugene M Johnson; Shan Ping Yu
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

2.  Pharmacological studies of Panax ginseng root: estimation of pharmacological actions of Panax ginseng root.

Authors:  K Takagi; H Saito; H Nabata
Journal:  Jpn J Pharmacol       Date:  1972-04

3.  Role of NMDA receptors in pentobarbital tolerance/dependence.

Authors:  S Oh; K Hoshi; I K Ho
Journal:  Neurochem Res       Date:  1997-07       Impact factor: 3.996

4.  L-type voltage-gated calcium channels modulate kainic acid neurotoxicity in cerebellar granule cells.

Authors:  M L Leski; S L Valentine; J T Coyle
Journal:  Brain Res       Date:  1999-05-15       Impact factor: 3.252

5.  G alpha(q/11) coupled to mammalian phospholipase C beta 3-like enzyme mediates the ginsenoside effect on Ca(2+)-activated Cl(-) current in the Xenopus oocyte.

Authors:  S Choi; H J Kim; Y S Ko; S W Jeong; Y I Kim; W F Simonds; J W Oh; S Y Nah
Journal:  J Biol Chem       Date:  2001-10-22       Impact factor: 5.157

6.  Coactivation of GABA(A) and GABA(B) receptor results in neuroprotection during in vitro ischemia.

Authors:  Cinzia Costa; Giorgia Leone; Emilia Saulle; Francesco Pisani; Giorgio Bernardi; Paolo Calabresi
Journal:  Stroke       Date:  2004-01-15       Impact factor: 7.914

7.  Ginsenoside Rh2 reduces ischemic brain injury in rats.

Authors:  Eun-Kyung Park; Min-Kyung Choo; Jin Kyung Oh; Jong Hoon Ryu; Dong-Hyun Kim
Journal:  Biol Pharm Bull       Date:  2004-03       Impact factor: 2.233

8.  Modulation of the GABAA receptor by depressant barbiturates and pregnane steroids.

Authors:  J A Peters; E F Kirkness; H Callachan; J J Lambert; A J Turner
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

Review 9.  Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions.

Authors:  David J Gladstone; Sandra E Black; Antoine M Hakim
Journal:  Stroke       Date:  2002-08       Impact factor: 7.914

Review 10.  Oxidative stress, glutamate, and neurodegenerative disorders.

Authors:  J T Coyle; P Puttfarcken
Journal:  Science       Date:  1993-10-29       Impact factor: 47.728

View more
  7 in total

1.  Antidepressant Effects of the Ginsenoside Metabolite Compound K, Assessed by Behavioral Despair Test and Chronic Unpredictable Mild Stress Model.

Authors:  Wu Song; Yan Guo; Shuang Jiang; Lin Wei; Zhi Liu; Xiaoyan Wang; Ying Su
Journal:  Neurochem Res       Date:  2018-05-22       Impact factor: 3.996

Review 2.  Yin and Yang of ginseng pharmacology: ginsenosides vs gintonin.

Authors:  Dong-soon Im; Seung-yeol Nah
Journal:  Acta Pharmacol Sin       Date:  2013-10-14       Impact factor: 6.150

3.  Morphine dependence is attenuated by red ginseng extract and ginsenosides Rh2, Rg3, and compound K.

Authors:  Taddesse Yayeh; Kyunghwa Yun; Soyong Jang; Seikwan Oh
Journal:  J Ginseng Res       Date:  2016-08-21       Impact factor: 6.060

4.  A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system.

Authors:  Hee Jin Kim; Pitna Kim; Chan Young Shin
Journal:  J Ginseng Res       Date:  2013-03       Impact factor: 6.060

Review 5.  Protective effects of ginseng on neurological disorders.

Authors:  Wei-Yi Ong; Tahira Farooqui; Hwee-Ling Koh; Akhlaq A Farooqui; Eng-Ang Ling
Journal:  Front Aging Neurosci       Date:  2015-07-16       Impact factor: 5.750

6.  Neuroprotective effects of 20(S)-protopanaxadiol against glutamate-induced mitochondrial dysfunction in PC12 cells.

Authors:  Dong-Ho Bak; Hyung Don Kim; Young Ock Kim; Chun Geun Park; Seung-Yun Han; Jwa-Jin Kim
Journal:  Int J Mol Med       Date:  2015-12-21       Impact factor: 4.101

7.  The Effects of Ginsenoside Compound K Against Epilepsy by Enhancing the γ-Aminobutyric Acid Signaling Pathway.

Authors:  Xiangchang Zeng; Kai Hu; Lulu Chen; Luping Zhou; Wei Luo; Chaopeng Li; Wenjing Zong; Siyu Chen; Qing Gao; Guirong Zeng; Dejian Jiang; Xiaohui Li; Honghao Zhou; Dong-Sheng Ouyang
Journal:  Front Pharmacol       Date:  2018-09-11       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.